Wh. Luo et al., SUBSTANCE-P-INDUCED MITOGENESIS IN HUMAN ASTROCYTOMA-CELLS CORRELATESWITH ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN-KINASE SIGNALING PATHWAY, Cancer research, 56(21), 1996, pp. 4983-4991
The neuropeptide substance P (SP) regulates many biological processes
through binding to and activating the SP receptor (NK-1 subtype). Acti
vation of the SP receptor induces mitogenesis in several cell types. I
n this study, we characterized the mitogenic response induced by SP pe
ptide in the U-373MG astrocytoma cell line and showed that activation
of the SP receptor induces [H-3]thymidine incorporation into DNA. We a
lso found that SP potently induces c-myc mRNA and protein in the U-373
MG cells. Tyrphostin A25, which blocks activity of tyrosine kinases, s
ignificantly inhibited SP-induced mitogenesis, suggesting that the mit
ogenic response induced by SP peptide involves phosphorylation by tyro
sine kinases. Furthermore, stimulation of the SP receptor activates ty
rosine phosphorylation and enzymatic activity of extracellular signal-
regulated kinases (Erk1 and Erk2), also called the mitogen-activated p
rotein kinases (MAPKs). This result suggests that MAPKs participate in
the SP peptide-induced signaling pathway. The addition of CP 96,345 -
2-(diphenylmethyl)-N-[(2-metoxyphenyl)-methyl]-1- azabicyclo[2.2.2]oct
an-3-amine]; an NK-1 receptor antagonist) or PD 098059 (MEK1 inhibitor
) inhibited both DNA synthesis and activation of the MAPK pathway, sub
stantiating that SP stimulates mitogenesis by activating the MAPK path
way through receptors of the NK-1 subtype. Our results demonstrate tha
t SP peptide is a strong mitogen in the U-373MG astrocytoma cell line
and establish a clear correlation between SP-induced mitogenesis and a
ctivation of MAPK signaling pathway.